纠正：药物审查：mtor抑制剂治疗胎儿心脏横纹肌瘤-走钢丝。

IF 2 3区医学 Q2 PEDIATRICS

Frontiers in Pediatrics Pub Date : 2025-09-09 eCollection Date: 2025-01-01 DOI:10.3389/fped.2025.1694368

Nadine Muschel, Michaela Höck, Elke Griesmaier, Samira Abdel Azim, Elisabeth Ralser, Christina Schreiner, Elisabeth Schermer, Ursula Kiechl-Kohlendorfer, Irene Mutz-Dehbalaie, Miriam Michel

引用次数: 0

摘要

[这更正了文章DOI: 10.3389/fped.2025.1649341.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Drug review: mTOR-inhibitor therapy in fetal cardiac rhabdomyoma-a tightrope walk.

[This corrects the article DOI: 10.3389/fped.2025.1649341.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Frontiers in Pediatrics Medicine-Pediatrics, Perinatology and Child Health

CiteScore

3.60

自引率

7.70%

发文量

2132

审稿时长

14 weeks

期刊介绍： Frontiers in Pediatrics (Impact Factor 2.33) publishes rigorously peer-reviewed research broadly across the field, from basic to clinical research that meets ongoing challenges in pediatric patient care and child health. Field Chief Editors Arjan Te Pas at Leiden University and Michael L. Moritz at the Children''s Hospital of Pittsburgh are supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Pediatrics also features Research Topics, Frontiers special theme-focused issues managed by Guest Associate Editors, addressing important areas in pediatrics. In this fashion, Frontiers serves as an outlet to publish the broadest aspects of pediatrics in both basic and clinical research, including high-quality reviews, case reports, editorials and commentaries related to all aspects of pediatrics.